Cristian Massacesi Appointed Executive Vice President, Chief Medical Officer and Head of Development at Bristol Myers Squibb
Bristol Myers Squibb announced the appointment of Cristian Massacesi, M.D., as Executive…
Boehringer Ingelheim and LEO Pharma Enter Partnership to Commercialize and Further Develop SPEVIGO®
Boehringer Ingelheim and LEO Pharma today announced an exclusive global license and…
Sanofi Completes Acquisition of Blueprint Medicines
Sanofi announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint),…
Sanofi Expands Immunology Footprint with $9.1 Billion Blueprint Medicines Acquisition
Sanofi has announced an agreement to acquire Blueprint Medicines Corporation, a US-based…
Avalo Therapeutics Appoints Dr. Rita Jain to Board as Phase 2 HS Trial Advances
Avalo Therapeutics, a clinical-stage biotechnology company focused on the treatment of immune…
AbbVie and ADARx Announce $335 Million Collaboration to Develop Cutting-Edge RNA Therapeutics
AbbVie and ADARx Pharmaceuticals, a late clinical-stage biotechnology company developing next-generation RNA…
AbbVie Awards Scholarships to 45 Students with Chronic Diseases
NORTH CHICAGO, Ill- AbbVie recently announced the 2024-2025 recipients of the AbbVie…
Bio-Rad Launches New StarBright Red Dyes for Immunology Research
May, 2024- Bio-Rad Laboratories announced the launch of three new StarBright™ Red…
